Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Sep 13, 2023 2:11pm
118 Views
Post# 35634342

RE:RE:RE:A bunch of SHOBS

RE:RE:RE:A bunch of SHOBSI would like to pick up another 5% or so to add and that way no dilution to my position for the recent raise.  But it looks like the inadequate SHOBS won't move the needle anywhere close to a decent purchase price.  Glad I have the position I have accumulated.

I like to buy low.  I will sell high but won't take a chance by trading this one now.  Even if it was $0.50 or $1.00 or even $2.00 per share.  Although once it gets over $2.00 I may cash out a modest amount.  

As you know I think we reach 90 enrolled by end of 2023 and it wouldn't surprise me to see a Baxter (Vantive) offer for Spectral at that time.  And the US biotech sector is surging ahead with several new IPO's leading the way right now.  Very hot sector.  When Vantive officially lists early in 2024 they'll be looking for some sizzle.  As you say a de-risked acquisition (Spectral) would be exactly what they need.  Now where are those shares at 20's or very low 30's?
<< Previous
Bullboard Posts
Next >>